CD274 and Hodgkins lymphoma: Since the original identification on Hodgkin’s lymphoma[10, 11], PD-L1 gene amplification has been described in many tumors, such as triple negative breast cancer[12–14], a subset of EBV-positive gastric cancer [10, 15], lung cancer[16, 17], and diffuse large B-cell lymphomas [18, 19].